Biomarkers and Biosimilars in Diabetes

 Biosimilars are biological medical products/molecules which are almost identical copies of an original product manufactured by different companies and an already FDA-approved biological product, referred to as a reference product.  Human bio monitoring (HBM) is a tool of health-related environmental monitoring.

 

 Diabetes is a major lifestyle disease, It is necessary to identify potential biomarkers associated with diabetes for early detection and proper management of diabetes.  Biomarkers are known as signature molecules or molecular markers or biological molecules found in blood, tissues and other body fluids. Biomarkers are used to monitor how well the body is responding to a particular disease. Hemoglobin A1c is considered as a biomarker for the presence of Diabetes Mellitus biosimilars in diabetes.

 

  • Scope and Role of Biomarkers
  • Biomarker Application in diabetes research
  • Novel Biomarkers
  • Biosimilar Development, Review, and Approval
  • Biosimilar and Interchangeable Products
  • Biosimilar and Interchangeable Products
  • Prescribing Biosimilar and Interchangeable Products
  • Biosimilar Product Information

Related Conference of Biomarkers and Biosimilars in Diabetes

June 15-16, 2020

29th European Diabetes Congress

Barcelona, Spain
June 23-24, 2020

29th World Diabetes & Heart Congress

Tokyo, Japan
July 15-16, 2020

3rd Global Diabetes Summit

Helsinki, Finland
July 15-16, 2020

28th International Diabetes and Healthcare Conference

Helsinki, Finland
July 20-21, 2020

Annual Congress on Diabetes, Metabolism and Obesity

Manila, Philippines
August 17-18, 2020

16th World Congress on Endocrinology & Diabetes

Copenhagen, Denmark
August 17-18, 2020

World Congress on Endocrinology and Metabolic Syndrome

Bangkok, Thailand
August 24-25, 2020

Global Summit on Diabetes & Endocrinology

Kyoto, Japan
August 24-25, 2020

Annual Summit on Diabetes and Endocrinology

Barcelona, Spain
September 21-22, 2020

Annual Congress on Endocrinology, Diabetes and Healthcare

Bangkok, Thailand
September 22-23, 2020

2nd Asia Pacific Endocrinology Congress

Singapore City, Singapore
September 28-29, 2020

4th Annual Congress on Diabetes, Obesity and Its Complications

Singapore City, Singapore
October 04-05, 2020

World Summit on Blood Glucose Monitoring

Beijing, China
October 07-08, 2020

International Summit on Diabetes

Barcelona, Spain
October 14-15, 2020

World Congress on Endocrinology & Diabetes

Rome, Italy
October 14-15, 2020

Global Congress on Endocrinology and Gynecology

Sydney, Australia
October 30-31, 2020

Annual Summit on Metabolomics

Vancouver, Canada
November 09-10, 2020

International Congress and Expo on Diabetic Care

Bangkok, Thailand
November 13-14, 2020

International Conference on Diabetes and Heart Diseases

Bangkok, Thailand
November 16-17, 2020

World Congress and Expo on Diabetes

Kyoto, Japan
November 16-17, 2020

2nd Asia Pacific Diabetes and Endocrinology Congress

Brisbane, Australia
November 18-19, 2020

Annual congress on Diabetes and Endocrinology Congress

Bangkok, Thailand
December 07-08, 2020

13th World Congress on Endocrinology and Metabolic Disorders

Auckland, Newzealand

Biomarkers and Biosimilars in Diabetes Conference Speakers

Recommended Sessions

Related Journals

Are you interested in